Anthropic IPO Likely to Price Above $70-$78 Range, Sources Say
Watch how Anthropic's IPO demand, explosive revenue growth and a $104 billion loss collide as the Claude maker readies a Nasdaq debut under the ticker ANT.

Key Takeaways
- Multiple sources say Anthropic is likely to price above its $70 to $78 range, a sign the order book is running hot.
- Revenue rose roughly 1,200% year over year, and Claude Code is the main engine behind it.
- The $104 billion net loss looks like a horror movie until you notice most of it is a fair value change on paper.
- Anthropic lands in a market that has grown skeptical of AI, so the welcome mat comes with a raised eyebrow.
- Class A buyers get a seat in the audience, not on the board, since founders' Class F shares hold 50.1% of the votes.

Anthropic's IPO isn't just another listing, it's a stress test for the whole AI trade. Multiple sources told CNBC's David Faber that the company is likely to price above its current range of $70 to $78 per share.
The maker of Claude was co-founded in 2021 by a group of researchers who left OpenAI, now its chief rival. It is slated to list on the Nasdaq under the ticker "ANT", stepping onto a stage where public markets have grown increasingly skeptical of AI.
So is this a coronation or a reckoning? The filings hold dazzling growth and a staggering loss, side by side. Let's get started.
Pricing the Anthropic IPO
Think of an IPO order book as a guest list that closes at the door. Anthropic plans to shut its list and lock in total demand at 4 p.m. ET on Tuesday, and multiple sources say the final price is likely to land above the range.
The current range sits at $70 to $78 per share, and the stock is slated to list on the Nasdaq under the ticker "ANT". Trading starts Nov. 19, so whatever price clears first becomes the opening bell's starting line.
Still, those sources spoke anonymously, and none of this is a formal company announcement. Until the final price is set, treat every figure as a draft rather than a verdict.
Tracking Explosive Revenue Growth
Revenue growth this steep usually belongs in a sci-fi plot. Anthropic reports $33.24 billion for the nine months ended in September, up roughly 1,200% from the same stretch a year earlier.
The engine is Claude Code, the AI coding tool whose popularity drove the company's explosive growth. Developers fell for it, and the revenue line followed them like a shadow at noon.
Growth that fast cuts both ways. A business scaling at this speed asks investors to trust the trajectory, because a prospectus can only photograph the past, not promise the next quarter.
Decoding the Net Loss
A $104 billion net loss sounds like a house fire. Anthropic reported exactly that for the nine-month stretch, yet most of it traces to the change in fair value of convertible notes and derivative liabilities.
That is largely an accounting swing, a scoreboard adjustment more than a cash bonfire. For comparison, the same period in 2025 carried a $25.1 billion loss, so the gap is wide but its biggest driver is a valuation line.
One analysis of the filing makes the same point: the figures look different depending on which item you watch. Operating deficits and paper valuation changes tell different stories, and a careful reader keeps them in separate columns.
Weighing Anthropic IPO Skepticism
Timing matters. Anthropic arrives roughly five months after SpaceX went public in a record offering that raised $85.7 billion, a tough act to follow.
The mood is cooler now. Public markets have grown increasingly skeptical of the AI trade, and antipathy toward the technology is mounting across the U.S. Hype has met its hecklers.
Anthropic seems to know it. Its prospectus runs more than 90 pages of risk factors, a safety-first reputation turned into homework for investors. Dario Amodei pairs his optimism with a demand that every risk be addressed as the benefits arrive.
Understanding Shareholder Control
Buying a slice of Anthropic is not the same as grabbing a steering wheel. The company is a Public Benefit Corporation, and the founders' Class F shares carry 50.1% of the voting rights, according to reports.
The Long-Term Benefit Trust selects the majority of the board, so the influence of Class A buyers is limited. Everyday investors do get a bigger invitation than usual, with retail allocation aiming for a maximum of 20%, against 5-10% in a typical IPO.
Translation: you get a seat in the audience, not on the board. That suits some portfolios, but it deserves a line in your own notes before any order goes in.
Long Story Short
Strip away the ticker and the story is a tug-of-war. On one side sits revenue up roughly 1,200% and demand strong enough that sources expect pricing above the range. On the other sit a $104 billion net loss, a skeptical market and more than 90 pages of risk factors. For readers, the smart move is patience plus homework. Read the loss in parts, since most of it is a fair value change rather than operating cost. Check the voting structure before falling for the headline, because Class A holders get limited influence. Whatever the final price, the debut on Nov. 19 will say plenty about how much faith the market still has in AI. Dario Amodei invited investors to join the next phase of the journey, and that invitation deserves a clear-eyed reply. Nothing here is investment advice, just a map of what is known and what is still unsettled.